F1000Research celebrates its second birthday, and looks back on two successful years of changing the status quo of science publishing with its unique model of immediate and transparent publishing.

Faculty of 1000, today launches an innovative new product, F1000Trials (http://f1000.com/trials), designed to enable rapid discovery and understanding of articles about clinical trials.

Faculty of 1000 (http://f1000.com) today announced a partnership with docwise (www.docwi.se) that will bring its F1000Prime article recommendations to the users of the docwise aggregated medical journal and news platform.

Failure to find an effective therapy for the chronic neurological disease multiple sclerosis (MS), despite 100 years of scientific research, could indicate a fundamental misunderstanding of the nature of the disease.

To celebrate the dedication of the F1000Prime Faculty in recommending papers of special importance across biology and medicine, Faculty of 1000 is delighted to announce the winners of the 2012 Faculty Member of the Year Awards.

An article published in F1000 Biology Reports discusses recent important advancements in the development of alternative methods of embryo evaluation and selection that could lead to improvements in the reliability of IVF treatments.

Faculty of 1000 (F1000) today announced the launch of a new intuitive PubMed search tool, the F1000 SmartSearch.

Faculty of 1000 announces the first in a series of awards marking the achievements of its Faculty members.

Faculty of 1000, today announced the launch of a new application that helps researchers explore the scientific content in biology and medicine included in Elsevier's SciVerse platform.

A recently published paper from Vascular Biosciences (VBS) has been selected by the Faculty of 1000 (F1000) as one of the top 2 percent of all published articles in the biological and medical sciences in 2011.

Ovarian and breast cancer therapies being developed that combine a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.

Sarah Greene, publishing and new media entrepreneur, is to become Editor-in-Chief of The Scientist magazine. Sarah's new role will include strengthening The Scientist's online presence and overseeing closer ties with Faculty of 1000